—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Protagonist Therapeutics Inc (PTGX) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 60 out of 100 (momentum 86 · quality 61 · valuation 10), as of 2026-11-03.
  • Signal: Pullback inside an uptrend stack — Trades -2.3% vs the 50-day and +19.2% vs the 200-day average, 13.3% below the 52-week high and +84.7% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Protagonist Therapeutics Inc trades 2.3% below its 50-day and 19.2% above its 200-day moving average. (as of 2026-11-02)

Protagonist Therapeutics is a clinical-stage biotechnology company that designs peptide-based drugs meant to work like larger biologic molecules but taken as oral or injectable treatments. Its lead programmes include a treatment for the blood disorder polycythemia vera and an oral therapy for plaque psoriasis, alongside earlier work in obesity and skin and lung disease.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the PTGX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pullback inside an uptrend stack

Trades -2.3% vs the 50-day and +19.2% vs the 200-day average, 13.3% below the 52-week high and +84.7% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the PTGX chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on PTGX?

Pullback inside an uptrend stack — Trades -2.3% vs the 50-day and +19.2% vs the 200-day average, 13.3% below the 52-week high and +84.7% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is PTGX above its 50-day and 200-day moving averages?

As of 2026-11-02, Protagonist Therapeutics Inc trades -2.3% below its 50-day and +19.2% above its 200-day average, with the 20-day -0.1% away.

How far is PTGX from its 52-week high?

13.3% below the 52-week high and 84.7% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.